Reducing health risks of diabetes on a national scale
Through the YMCA’s Diabetes Prevention Program, the Y is scaling an evidence-based intervention designed to help adults reduce their risk for the development of type 2 diabetes through lifestyle behavior change. To date, more than 27,000 people have participated in the Y’s program in more than 1,095 program locations; this represents a 36% growth in the number of participants served over the last year.
In order to scale the program effectively, the Y has conducted a significant amount of analysis on costs across a wide variety of community sizes in order to determine how best to coach Ys around practices related to program operations, anticipated costs/revenue and projected participants in effort to create a sustainable diabetes prevention delivery model. Ensuring a sustainable model has meant cultivating a healthy revenue mix that includes third-party insurance coverage, corporate wellness contracts, self-pay, and grant funding.
Learning Areas:Chronic disease management and prevention
Implementation of health education strategies, interventions and programs
Discuss how nationwide community-based organizations can leverage their networks to impact public health. Explain the process by which a community-based organization with a nationwide network can serve as an adjunct provider of services traditionally delivered by healthcare providers. Describe the various organizational and community components that need to be considered when implementing a chronic disease prevention program to reduce risk of diabetes.
Keyword(s): Chronic Disease Prevention, Diabetes
Qualified on the content I am responsible for because: I am Director of Chronic Disease Prevention Programs and I help lead and advance the dissemination of chronic disease prevention programs designed reduce medical risks, which includes day to day oversight of activities related to the YMCAâs Diabetes Prevention Program.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.